Add-on Dupilumab for AFRS as Postoperative Therapy (ADAPT)

Clinical trial NCT05545072 · TERMINATED

Trial details

NCT number: NCT05545072
Sponsor: Emory University
Status: TERMINATED
Phase: Phase 3
Study type: INTERVENTIONAL

Allergic Fungal Rhinosinusitis

Start date: 2023-10-26
Primary completion: 2024-07-10
Enrollment: 5

View on ClinicalTrials.gov

Track trials programmatically

Sponsors, conditions and status changes through the Atlas API.